Shabayek Sarah, Vogel Verena, Jamrozy Dorota, Bentley Stephen D, Spellerberg Barbara
Department of Microbiology and Immunology, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.
Institute of Medical Microbiology and Hygiene, University Hospital Ulm, 89081 Ulm, Germany.
Microorganisms. 2022 Dec 22;11(1):38. doi: 10.3390/microorganisms11010038.
(1) Background: or Group B Streptococcus (GBS) causes severe neonatal infections with a high burden of disease, especially in Africa. Maternal vaginal colonization and perinatal transmissions represent the common mode of acquiring the infection. Development of an effective maternal vaccine against GBS relies on molecular surveillance of the maternal GBS population to better understand the global distribution of GBS clones and serotypes. (2) Methods: Here, we present genomic data from a collection of colonizing GBS strains from Ismailia, Egypt that were sequenced and characterized within the global JUNO project. (3) Results: A large proportion of serotype VI, ST14 strains was discovered, a serotype which is rarely found in strain collections from the US and Europe and typically not included in the current vaccine formulations. (4) Conclusions: The molecular epidemiology of these strains clearly points to the African origin with the detection of several sequence types (STs) that have only been observed in Africa. Our data underline the importance of continuous molecular surveillance of the GBS population for future vaccine implementations.
(1)背景:B族链球菌(GBS)会引发严重的新生儿感染,疾病负担沉重,在非洲尤为如此。孕产妇阴道定植和围产期传播是感染的常见途径。开发一种有效的抗GBS孕产妇疫苗依赖于对孕产妇GBS群体进行分子监测,以更好地了解GBS克隆和血清型的全球分布情况。(2)方法:在此,我们展示了来自埃及伊斯梅利亚的一组定植GBS菌株的基因组数据,这些菌株在全球JUNO项目中进行了测序和特征分析。(3)结果:发现了很大比例的血清型VI、ST14菌株,这种血清型在美国和欧洲的菌株库中很少见,通常也不包括在当前的疫苗配方中。(4)结论:这些菌株的分子流行病学明确表明其起源于非洲,检测到了几种仅在非洲观察到的序列类型(STs)。我们的数据强调了对GBS群体进行持续分子监测对于未来疫苗实施的重要性。